We are pleased to announce that the second phase of the Rethinking Alzheimer's disease project kicks off! Rethinking Alzheimer's Disease, coordinated by EBC, in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), is a research-driven project offering policy recommendations to make tangible changes with the aim to improve the lives of [...]
After the launch of the policy report 'Rethinking Schizophrenia: Beyond the Voices' in March 2024, falling under the 1st phase of the Rethinking Schizophrenia project, we are pleased to announce that the second phase, focusing on the schizophrenia care pathway, officially kicks off on the occasion of the European Mental Health Week! The Rethinking [...]
The Value of Treatment (VOT) research project, initiated and coordinated by EBC, aims to identify treatment gaps and causing factors along the care pathway and propose solutions to address them; assess health gains and socio-economic impacts resulting from best practice healthcare interventions, in comparison with current care or no treatment. Furthermore, its objective is to [...]
